Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Genetic Predisposition to Disease
Open-data reference.
12 US clinical trials · 9 currently recruiting
Active & Recent Trials
Helix Research Network
Helix
NCT06057181
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Brigham and Women's Hospital
NCT01258231
Blood Markers of Early Pancreas Cancer
University of Nebraska
NCT03568630
VIGOR: Virtual Genome Center for Infant Health
Boston Children's Hospital
NCT05205356
Prostate Cancer Genetic Risk Evaluation and Screening Study
Massachusetts General Hospital
NCT05129605
Microbiome and Association With Implant Infections
University of California, San Francis
NCT05020574
Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
Boston Children's Hospital
NCT03967743
Healthy Volunteers Study
Abramson Cancer Center at Penn Medicine
NCT06962059
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Dana-Farber Cancer Institute
NCT05759143
This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults
University of Missouri-Columbia
NCT05386914
NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children
Icahn School of Medicine at Mount Sinai
NCT03738098
4R for Guideline Indicated BRCA Testing of Breast Center Patients
Northwestern University
NCT01320540
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Genetic Predisposition to Disease Trial Landscape
ClinicalTrials.gov lists 12 US studies indexed under Genetic Predisposition to Disease, and 9 of those are currently open to recruitment — roughly 75% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Genetic Predisposition to Disease shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Genetic Predisposition to Disease is led by Boston Children's Hospital with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Genetic Predisposition to Disease?
PlainTrial tracks 12 US clinical trials for Genetic Predisposition to Disease, of which 9 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Genetic Predisposition to Disease?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.